Irineu Loturco | Health Professions | Best Researcher Award

Published on by Invention Awards

Prof Dr. Irineu Loturco | Health Professions | Best Researcher Award

Prof. Dr. Irineu Loturco | Federal University of Sao Paulo | Brazil 

Prof. Dr. Irineu Loturco Filho (born May 22, 1972, Brazil) is a distinguished researcher, educator, and practitioner in sports science, specializing in high-performance training, neuromuscular adaptations, strength, power, and speed development. He holds a degree in Sports from the University of São Paulo (1999), a Professional Master’s in High-Performance Sports from Universidad Autónoma de Madrid (2009), and both a Master’s (2010) and PhD (2014) in High-Performance Sports from Universidad Pablo de Olavide, Spain, where his research focused on the effects of training load sequencing on strength, speed, and muscle power. Loturco currently serves as Director of Sport Science & Research Leader at the Núcleo de Alto Rendimento Esportivo de São Paulo (NAR-SP), coordinating postgraduate programs in training methodology and supervising research on training periodization, performance monitoring, and neuromuscular development. He is also a professor and advisor at the Federal University of São Paulo (UNIFESP) and a visiting professor at the University of South Wales, contributing to both national and international sports science research. Over his career, he has worked with elite athletes and professional teams including Clube Atlético Mineiro, Sociedade Esportiva Palmeiras, and Sport Club Corinthians Paulista, as well as national organizations such as the Brazilian Football Confederation and Brazilian Karate Confederation. His current research investigates strategies to enhance athletic performance, including weighted vest training, seasonal performance variation, and injury prevention. Recognized internationally for his contributions, Loturco has received awards such as the 2019 SCS Investigator Award and honors for his work in adaptive sports and high-performance athlete development, solidifying his position as a leading authority in strength and conditioning science.

Profile: Orcid

Featured Publications

Survey Studies: Connecting Sport Science to Coaching Practice – International Journal of Sports Physiology and Performance

Training at Different Velocity Zones: Does It Really Matter? – International Journal of Sports Physiology and Performance

Neuromuscular and Performance Responses to Resisted Sprint Loads in Elite Female Sprinters

Effects of a Short-Term Ballistic Training Program on Performance and Strength Deficit in Elite Youth Female Soccer Players – Sports,

Effects of Loaded and Unloaded Jumps Used as Priming Activities in Elite Male Rugby Union Players

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Published on by Invention Awards

Dr. James C. L. Chow | Quantum Computing | Best Researcher Award

Princess Margaret Cancer Centre, Canada.

Dr. James Chun Lam Chow, PhD, FCCPM, FInstP, FIET, SMIEEE, PPhys, CPhys, CSci, is a distinguished medical physicist specializing in radiation oncology and artificial intelligence applications in healthcare. He is currently an Associate Professor in Material Science and Engineering at the University of Toronto and a Clinician Investigator at the Princess Margaret Cancer Research Institute. With over two decades of experience in medical physics, his research focuses on AI-driven healthcare solutions, radiation therapy optimization, and Monte Carlo simulations for cancer treatment.

Profile

Google Scholar

Education🎓

Dr. James C. L. Chow earned his PhD in Physics from the University of Hong Kong in 1995 under the supervision of Prof. Peter Fung, following a BSc in Applied Physics (First Class Honours) from City University of Hong Kong in 1992. He was awarded a Croucher Postdoctoral Fellowship at the University of Cambridge (1995-1997), then continued his research as a Postdoctoral Researcher at the University of Toronto (1997-1998) and later as a Postdoctoral Fellow at McMaster University (1998-2000). Transitioning into medical physics, he completed his Medical Physics Residency at the London Regional Cancer Centre (2000-2002), gaining clinical expertise in radiation therapy and medical imaging.

Professional Experience🌟

Dr. James C. L. Chow is an accomplished medical physicist and academic with extensive experience in radiation oncology and materials science. He is currently an Associate Professor in the Department of Materials Science and Engineering at the University of Toronto (2025–Present) and has been an Associate Professor in the Department of Radiation Oncology at the University of Toronto since 2019. In addition to his academic roles, he serves as a Medical Physicist at Princess Margaret Cancer Centre (2005–Present), where he also leads as the Physics On-Call Lead (2010–Present). His research contributions are further reflected in his role as a Clinician Investigator at the Princess Margaret Cancer Research Institute (2023–Present) and his affiliation with the Acceleration Consortium at the University of Toronto (2024–Present).

Previously, Dr. Chow held multiple key positions, including Assistant Professor in Radiation Oncology at the University of Toronto (2006–2019) and Medical Physics Site Lead for Skin Cancer at Princess Margaret Cancer Centre (2010–2015). Before joining Princess Margaret, he worked as a Medical Physicist and Deputy Radiation Safety Officer at Grand River Regional Cancer Centre (2002–2005). He has also contributed to academia as an Adjunct Professor at Ryerson University and the University of Waterloo (2005–2010). His career reflects a deep commitment to advancing medical physics, cancer treatment, and interdisciplinary research in materials science and engineering.

Research Interests📚

Dr. Chow’s research focuses on:

Radiation Oncology & Medical Physics: Treatment optimization using Monte Carlo simulations

Artificial Intelligence in Healthcare: AI-driven diagnostic tools and chatbot applications in oncology

Nanotechnology in Radiation Therapy: Gold nanoparticle-enhanced radiotherapy

Clinical Data Analysis: Predictive modeling for cancer treatment outcomes

Awards & Recognitions🏆

2024 Outstanding Reviewer, Nuclear Engineering and Technology Journal

2024 Most-Viewed Article, JMIR Cancer

2024 Outstanding Author of the Year, AIMS Biophysics Journal

2019 Top Peer Reviewer, Web of Science Group

2012 Outstanding Reviewer, Medical Physics Journal

2010 SciNet Local Resource Allocation Award (1 million supercomputing hours for Monte Carlo simulations)

Selected Publications📖

Gold nanoparticles for drug delivery and cancer therapy
S Siddique, JCL Chow
Applied Sciences 10(11), 3824 (2020) – Cited: 382

Chatbot for health care and oncology applications using artificial intelligence and machine learning: Systematic review
L Xu, L Sanders, K Li, JCL Chow
JMIR Cancer 7(4), e27850 (2021) – Cited: 375

Application of nanomaterials in biomedical imaging and cancer therapy
S Siddique, JCL Chow
Nanomaterials 10(9), 1700 (2020) – Cited: 325

Irradiation of gold nanoparticles by X‐rays: Monte Carlo simulation of dose enhancements and the spatial properties of secondary electron production
MKK Leung, JCL Chow, BD Chithrani, MJG Lee, B Oms, DA Jaffray
Medical Physics 38(2), 624-631 (2011) – Cited: 311

Machine learning in healthcare communication
S Siddique, JCL Chow
Encyclopedia 1(1), 220-239 (2021) – Cited: 142

 

 

Mr. Fayez Alanazi | Mental Health | Best Researcher Award

Published on by Invention Awards

Mr. Fayez Alanazi | Mental Health | Best Researcher Award

Saudi Red Crescent Authority, Saudi Arabia.

Fayez Mutairan Alanazi is an experienced emergency medical professional at the Saudi Red Crescent Authority, with over a decade in frontline medical response. He holds a Master’s degree in Risk Management and has expertise in trauma life support and major incident management. His research focuses on mental health in emergency medical services, particularly PTSD among paramedics. He has contributed to discussions on occupational stress and resilience-building programs, shaping mental health interventions for frontline responders.

Profile

Google Scholar

🎓 Education

Fayez Mutairan Alanazi has a strong academic foundation in emergency medical services and risk management. He earned a Master’s degree in Risk Management from Midocean University (2024), equipping him with expertise in crisis response and disaster preparedness. In 2020, he completed a Higher Diploma in Health Media at Imam Mohammad bin Saud University, enhancing his communication skills in healthcare settings. His Bachelor’s degree in Emergency Medical Services from Inaya College (2017) provided him with in-depth knowledge of prehospital care. Additionally, he holds a Diploma in Emergency Medicine from Future Gate Institute (2012), which laid the foundation for his career in frontline emergency response.

💼 Experience

Fayez Mutairan Alanazi has been a dedicated Emergency Medical Services Professional at the Saudi Red Crescent Authority since 2012, with over a decade of hands-on experience in frontline medical response. His role involves providing critical prehospital care, managing major incidents, and ensuring efficient trauma life support. In addition to his medical career, he also worked as a Gym Manager for five years, where he specialized in fitness and rehabilitation programs, promoting physical well-being and injury recovery. His combined experience in emergency response and health management has strengthened his expertise in both medical intervention and preventative healthcare.

🔬 Research Interests

Mental Health & Psychology: PTSD among paramedics, resilience-building programs

Prehospital Care: Innovation and AI applications in emergency medical diagnosis

Trauma & Emergency Response: Major incident management and medical response strategies

📚 Publications

Alanazi, F. M., et al. (2025). Assessing post-traumatic stress disorder among paramedics on the frontlines at the Saudi Red Crescent. European Journal of Trauma & Dissociation, 9(1), 100492. [DOI Link] (Cited by X articles)

Saudi Paramedics' Perceptions of Innovation in Prehospital Care for Trauma Patients – This study explores how paramedics in Saudi Arabia perceive and adopt new technologies and practices in trauma management, aiming to improve emergency response efficiency.(on going)

Artificial Intelligence Applications in Myocardial Infarction Diagnosis and Management: A Systematic Review with a Focus on Adoption in Saudi Arabia – This research investigates the role of AI in diagnosing and managing heart attacks, emphasizing its potential integration into Saudi Arabia’s healthcare system to improve early detection and patient outcomes.(on going)

Dr. Jad El Masri | Medical Research | Young Scientist Award

Published on by Invention Awards

Dr. Jad El Masri | Medical Research | Young Scientist Award

American University of Beirut, Lebanon.

Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.

Profile

Google Scholar

🎓 Education

Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).

💼 Experience

Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.

🔬 Research Interests

Oncology – Brain cancer, genetic biomarkers, metastasis

Epidemiology – Risk factors, diet effects, environmental exposure

Neurosurgery – Computational biology, single-cell DNA sequencing

🏆 Awards & Recognitions

Young Scientist Award – Recognized for contributions to neuroscience research

Editorial Board Member – Journal of Public Health Research

Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons

📚 Selected Publications

1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34

2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27

3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23

4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22

5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22

 

 

 

 

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

MUSC Health University Medical Center, United States.

Dr. Charles A. Reitman is a distinguished orthopedic surgeon specializing in spine surgery with decades of experience in medical education, research, and patient care. He has held prestigious academic positions and received numerous awards for his contributions to orthopedic and spinal surgery. Dr. Reitman is widely recognized for his expertise in minimally invasive spine techniques, spinal trauma, and disc arthroplasty.

Profile

Scopus

Orcid

🎓 Education

Charles A. Reitman, MD, pursued his undergraduate studies at the University of California, Davis, earning a BS in Animal Physiology (1974-1978). He then completed a BS and Certificate in Physical Therapy at UCSF, San Francisco (1978-1979), which provided him with foundational expertise in rehabilitation and movement sciences. Dr. Reitman later obtained his MD in Medicine from Baylor College of Medicine (1991-1995), where he developed a strong foundation in clinical practice and surgical techniques. Following medical school, he specialized in orthopedic surgery through a residency at Baylor College of Medicine (1995-2000), refining his skills in musculoskeletal care. To further specialize, he completed a fellowship in Orthopedic Surgery Spine at Baylor College of Medicine (2000-2001), gaining advanced training in complex spinal procedures.

🏥 Experience

Dr. Charles A. Reitman has had a distinguished career in orthopedic surgery, with extensive experience in both academic and clinical settings. Since 2015, he has served as a Professor of Orthopaedics at the Medical College of South Carolina, where he contributes to research, education, and advanced spinal surgery techniques. Prior to this, he was a Professor of Orthopedic Surgery at Baylor College of Medicine (2012-2015), mentoring future surgeons and leading innovative surgical advancements. His tenure at Baylor also included roles as an Associate Professor (2007-2012) and Assistant Professor (2001-2007), during which he played a pivotal role in shaping orthopedic residency programs and conducting groundbreaking research in spine surgery.

🔬 Research Interests

Spinal Surgery & Biomechanics

Minimally Invasive Spine Techniques

Disc Arthroplasty & Spinal Trauma

Spinal Deformity & Degenerative Disorders

Orthopedic Surgery Innovations

🏆 Awards & Honors

UC Davis – Highest Honors (1978)

Alpha Omega Alpha Honor Society (1995)

Baylor College of Medicine – Honors (1995)

Most Outstanding Poster – NASS (1999)

Outstanding Orthopedic Faculty, BCM (2004, 2012, 2013, 2014, 2015)

America’s Top Orthopedists (2007, 2010)

Best Doctors (2007, 2008, 2013)

Texas Super Doctors (2009)

Most Compassionate Doctor Award (2010-2016)

Top 10 Doctor (2014)

Elected into American Orthopedic Association (2011)

MUSC Ortho Faculty of the Year (2019, 2023)

Marquis Who’s Who Lifetime Award (2018)

📚 Selected Publications

Establishing case volume benchmarks for ACGME-accredited orthopedic surgery of the spine fellowship training – Spine J, 2024

Reference Data for Diagnosis of Spondylolisthesis and Disc Space Narrowing Based on NHANES-II X-rays – Bioengineering (Basel), 2024

Regional structure-function relationships of lumbar cartilage endplates – J Biomech, 2024

Diagnosis of spine pseudoarthrosis based on biomechanical properties of bone – Spine J, 2024

ACR Appropriateness Criteria® Stress (Fatigue-Insufficiency) Fracture Including Sacrum – J Am Coll Radiol, 2024

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Published on by Invention Awards

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link

 

 

 

 

 

Herman Perroud | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98